Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of California | Diversity, Equity, and Inclusion Champion Training | 10/2020 | |
Duke University | Ph.D. | Biochemistry/Cell Biology | 05/1996 |
Duke University Medical Center | Pediatric Fellowship | Hematology/Oncology | 07/1993 |
Duke University Medical Center | Residency | Pediatrics | 07/1989 |
Johns Hopkins University | M.A. | Creative Writing | 05/1986 |
University of Maryland School of Medicine | M.D. | Medicine | 05/1985 |
Johns Hopkins University | B.S. | Natural Sciences | 05/1981 |
Awards & Honors
Award | Conferred By | Date |
---|---|---|
Eli Lilly Genetic Medicine Grand Challenge Winner | Eli Lilly / Nucleate | 2023 |
Nucleate Pillar Venture Prize | Pillar VC / Nucleate | 2023 |
Director, Swim Across America National Laboratory | Children's Hospital and Research Center Oakland | 2015 |
John and Edna Beck Chair in Pediatric Cancer Research | Children's Hospital and Research Center Oakland | 2012 |
American Society of Clinical Investigation member | ASCI | 2006 |
Clinical Trials
- Related Conditions: SPLIS| Start Date: | End Date:
- SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International) (NCT04885179)Related Conditions: Sphingolipidoses, Enzyme Deficiency, SPLIS| Start Date: | End Date:
Grants and Funding
- Providing a cure for sphingosine phosphate lyase insufficiency syndrome (SPLIS) through adeno-associated viral mediated SGPL1 gene therapy | CIRM | 2022-04-01 - 2024-03-31 | Role: Principal Investigator
- SPLIS Patient Finding | Catalyst Program (UCSF) | 2022-02-01 - 2023-02-06 | Role: Principal Investigator
- Endogenous and Dietary Sphingolipids as Modulators in Inflammatory Bowel Disease | NIH | 2018-06-15 - 2022-05-31 | Role: Principal Investigator
- S1P Lyase in colon cancer | NIH | 2007-07-01 - 2018-01-31 | Role: Principal Investigator
- Agilent 6490 Triple Quadrupole Mass Spectrometer | NIH | 2014-06-01 - 2015-05-31 | Role: Principal Investigator
- Sphingolipid Metabolism in Drosophila Development | NIH | 2003-09-01 - 2015-02-28 | Role: Principal Investigator
- IVIS Spectrum small animal imaging system | NIH | 2013-06-15 - 2014-06-14 | Role: Principal Investigator
- FASEB SRC on Lysophospholipd Mediators in Health and Disease | NIH | 2011-08-12 - 2012-08-11 | Role: Principal Investigator
- Soy sphingadienes and related compounds in colon cancer chemoprevention and treat | NIH | 2009-09-01 - 2012-07-31 | Role: Principal Investigator
- Endogenous sphingosine-1-phosphate as a radioprotector of intestinal tissues | NIH | 2007-09-01 - 2011-02-28 | Role: Principal Investigator
- Sphingosine Phosphate:Regulation and Role in Cancer | NIH | 1998-09-01 - 2011-02-28 | Role: Principal Investigator
- CERAMIDE MEDIATED SIGNAL TRANSDUCTION IN YEAST | NIH | 1993-07-01 - 1998-06-30 | Role: Principal Investigator
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 133
- Age-dependent reference intervals for cerebrospinal fluid (CSF) and urine heparan sulfate (HS) and dermatan sulfate (DS) and CSF gangliosides.| | UCSF Research Profile
- Sphingosine phosphate lyase insufficiency syndrome as a primary immunodeficiency state.| | PubMed
- Factors influencing survival in sphingosine phosphate lyase insufficiency syndrome: a retrospective cross-sectional natural history study of 76 patients.| | PubMed
- Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 + cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype.| | PubMed
- 109 Chemical development of dual species–host and Aspergillus fumigatus–sphingosine-1-phosphate lyase inhibitors as therapeutic strategy in cystic fibrosis.| | UCSF Research Profile
- Melanocortin-receptor 4 activation modulates proliferation and differentiation of rat postnatal hippocampal neural precursor cells.| | PubMed
- The fate of intracellular S1P regulates lipid droplet turnover and lipotoxicity in pancreatic beta-cells.| | PubMed
- AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesis.| | PubMed
- Gene therapy with AAV9-SGPL1 in an animal model of lung fibrosis.| | PubMed
- Prevalence estimate of sphingosine phosphate lyase insufficiency syndrome in worldwide and select populations.| | PubMed